サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1553945

ストレッチマーク治療の市場規模、シェア、動向分析レポート：治療別、地域別、セグメント予測、2024年～2030年

Stretch Marks Treatment Market Size, Share & Trends Analysis Report By Treatment (Topical Products, Laser, Microdermabrasion, Oils & Serums), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 110 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ストレッチマーク治療の市場規模、シェア、動向分析レポート：治療別、地域別、セグメント予測、2024年～2030年
出版日: 2024年08月01日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ストレッチマーク治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のストレッチマーク治療市場規模は、2024年から2030年にかけてCAGR 9.0％を記録し、2030年までに5億2,913万米ドルに達すると予測されています。

妊娠中にできるストレッチマークの治療に関する女性の意識の高まりが、成長を大きく後押ししています。また、青少年やティーンエイジャーにおけるストレッチマークの有病率の増加は、その治療需要に拍車をかけると予測されています。

北米では肥満人口が多く、同地域の市場を大きく牽引しています。これは、消費者ターゲットを拡大し、市場での存在感を強化するために、プレーヤーにとって好機です。さらに、同地域における主要プレーヤーの増加も競合を促進する要因であり、ストレッチマーク治療市場にプラスの影響を与えています。

ストレッチマークを治療するための外用製品を販売するオンラインポータルの数が増加していることも、プレーヤーにとっての好機です。したがって、主要プレーヤーはこれらのオンラインポータルを通じて販売を拡大し、製品ポートフォリオを拡大することができます。さらに、外用製品に対する消費者の嗜好が需要を増大させており、市場に影響を与えています。

新製品発売の増加、パートナーシップやイノベーションなどの成長戦略の採用が市場の動向となっています。アジア太平洋地域の経済成長と消費者の消費力の上昇も、市場の成長にプラスの影響を与えています。

ストレッチマーク治療市場のレポートハイライト

  • 妊娠、肥満、双子や大きな赤ちゃんの出産歴、急激な体重減少や増加、その他によって引き起こされるストレッチマークの症例が増加しているため、局所製品が主要セグメントとなっています。
  • クリーム分野は、高い需要による売上増加、消費者の可処分所得の増加、クリームのプロモーションの増加により、予測期間中に大幅な成長が見込まれています。
  • フラクショナルレーザー分野は、肌のトーンを改善し、一般的な老化の兆候を軽減し、肌の質感を向上させる製品であるため、予測期間中に大幅な成長が見込まれています。
  • パルスダイレーザーの分野も、患者の安全性が完全に保証されていること、マシンがパルスを発する直前にコールドスプレーを発生させるため麻酔が不要であること、痛みの感覚がないことから、大きく成長しています。
  • アジア太平洋は、可処分所得の増加、ライフスタイルの変化、オンラインショッピングポータルの出現により、ストレッチマーク治療市場の支配的なセグメントです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界のストレッチマーク治療市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • ストレッチマーク治療市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ストレッチマーク治療市場：治療別推定・動向分析

  • ストレッチマーク治療市場：治療ダッシュボード
  • ストレッチマーク治療市場：治療変動分析
  • ストレッチマーク治療市場規模と予測および動向分析、治療別、2018～2030年
  • 局所用製品
  • レーザ
  • マイクロダーマブレーション

第5章 ストレッチマーク治療市場： 国、治療の地域別推定・動向分析。

  • 世界のストレッチマーク治療市場：地域別ダッシュボード
  • 市場規模と予測動向分析、2018年から2030年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 主要メーカーによる最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2023年
    • Alliance Pharma PLC
    • Basq Skincare
    • Clarins Group
    • Candela Corporation
    • Dermaclara Inc.
    • ET Browne Drug Co. Inc.（Palmers）
    • Helix BioMedix Inc.
    • HRA Pharma
    • Laboratoires Expanscience
    • Union Swiss（Pty）Ltd
    • Weleda AG Source
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 Global stretch marks treatment market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 7 U.S stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 Canada stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 Mexico stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 Europe stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 UK stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13 Germany stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 14 France stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Italy stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 16 Spain stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 Denmark stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 18 Sweden stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 Norway stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 22 Japan stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 China stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 24 India stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Australia stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 26 Thailand stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 South Korea stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 28 Latin America stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 29 Latin America stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 30 Brazil stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Argentina stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32 MEA stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 33 MEA stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 South Africa stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 UAE stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 37 Kuwait stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 Participant's overview
  • Table 39 Financial performance
  • Table 40 Key companies undergoing expansions
  • Table 41 Key companies undergoing acquisitions
  • Table 42 Key companies undergoing collaborations
  • Table 43 Key companies launching new types/services
  • Table 44 Key companies undergoing partnerships
  • Table 45 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Stretch marks treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain - based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Stretch marks treatment market revenues, 2023, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Stretch marks treatment market treatment outlook:
  • Fig. 14 Stretch marks treatment market: reatment movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global creams market, 2018 - 2030 (USD Million)
  • Fig. 17 Global oils & serums market, 2018 - 2030 (USD Million)
  • Fig. 18 Global lotions market, 2018 - 2030 (USD Million)
  • Fig. 19 Global laser market, 2018 - 2030 (USD Million)
  • Fig. 20 Global fractional laser market, 2018 - 2030 (USD Million)
  • Fig. 21 Global pulse - dye laser market, 2018 - 2030 (USD Million)
  • Fig. 22 Global others market, 2018 - 2030 (USD Million)
  • Fig. 23 Global microdermabrasion market, 2018 - 2030 (USD Million)
  • Fig. 24 Regional market place: Key takeaways
  • Fig. 25 North America stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 31 UK stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 32 France stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 Asia Pacific stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 Japan stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 China stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 India stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 Australia stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 Latin America stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Brazil stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 MEA stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 43 South Africa stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Saudi Arabia stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 45 Market Participant Categorization
  • Fig. 46 Strategy mapping
目次
Product Code: GVR-2-68038-977-7

Stretch Marks Treatment Market Growth & Trends:

The global stretch marks treatment market size is expected to reach USD 529.13 million by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing awareness among women regarding the treating stretch marks caused during pregnancy is significantly driving the growth. Also, the growing prevalence of stretch marks in adolescents and teenagers is predicted to fuel the demand for their treatment.

High number of obese population in North America is majorly driving the market in the region. This is an opportunity for the players for expanding their consumer target and strengthening their market presence. Moreover, the increasing number of key players in the region is another factor driving the competition, thereby positively influencing the stretch marks treatment market.

Growing number of online portals for the sale of topical products for treating stretch marks is another opportunity for the players. The key players can thus, increase their sale through these online portals and expand their product portfolio. Moreover, consumer preference for topical products is augmenting its demand, thus affecting the market.

Rise in the launch of new products and adoption of growth strategies, such as partnerships and innovations are trending in the market. Growing Asia Pacific economies and rise in spending power of consumers in these regions is also influencing the market growth positively.

Stretch Marks Treatment Market Report Highlights:

  • Topical products is the leading segment owing to increasing cases of stretch marks caused due to pregnancy, obesity, history of delivering twins or large babies, pale skin, sudden weight loss or gain, and others
  • Creams segment is expected to grow considerably during the forecast period owing to increased sales due to high demand, rise in disposable income of consumers, and increased promotion of creams
  • Fractional laser segment is expected to grow substantially over the forecast period, since these products improve the skin tone, reduce the common signs of aging, and enhance the skin texture
  • Pulse-dye lasers domain is also growing significantly due to completely safety assurance for the patients, no need of anesthesia since the machine produces cold spray just before pulsing, eliminating the pain sensation
  • Asia Pacific is the dominant segment in the stretch marks treatment market owing to increasing disposable income, changing lifestyle, and emerging online shopping portals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment Segment
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Stretch Marks Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of obesity globally
      • 3.2.1.2. Rising number of pregnancies and concerns about stretch marks
      • 3.2.1.3. Advancements in treatment technologies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of the advanced treatment
      • 3.2.2.2. Risk of side effects and complications
  • 3.3. Stretch Marks Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Stretch Marks Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Stretch Marks Treatment Market: Treatment Dashboard
  • 4.2. Stretch Marks Treatment Market: Treatment Movement Analysis
  • 4.3. Stretch Marks Treatment Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Topical Products
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Creams
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Oils & Serums
      • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4. Lotions
      • 4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Laser
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Fractional Laser
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Pulse-Dye Laser
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1 Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Microdermabrasion
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Stretch Marks Treatment Market: Regional Estimates & Trend Analysis by Country, Treatment.

  • 5.1. Global Stretch Marks Treatment Market: Regional Dashboard
  • 5.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key country dynamics
      • 5.3.4.2. Regulatory framework/ reimbursement structure
      • 5.3.4.3. Competitive scenario
      • 5.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key country dynamics
      • 5.4.9.2. Regulatory framework/ reimbursement structure
      • 5.4.9.3. Competitive scenario
      • 5.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2023
    • 6.3.4. Alliance Pharma PLC
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Basq Skincare
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Clarins Group
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Candela Corporation
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Dermaclara Inc.
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. E.T. Browne Drug Co. Inc. (Palmers)
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Helix BioMedix Inc.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. HRA Pharma
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Laboratoires Expanscience
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Union Swiss (Pty) Ltd
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. Weleda AG Source
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives